Correlation Between Pfizer and Innovator Premium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Innovator Premium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Innovator Premium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Innovator Premium Income, you can compare the effects of market volatilities on Pfizer and Innovator Premium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Innovator Premium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Innovator Premium.

Diversification Opportunities for Pfizer and Innovator Premium

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and Innovator is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Innovator Premium Income in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Premium Income and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Innovator Premium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Premium Income has no effect on the direction of Pfizer i.e., Pfizer and Innovator Premium go up and down completely randomly.

Pair Corralation between Pfizer and Innovator Premium

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Innovator Premium. In addition to that, Pfizer is 10.87 times more volatile than Innovator Premium Income. It trades about -0.08 of its total potential returns per unit of risk. Innovator Premium Income is currently generating about 0.23 per unit of volatility. If you would invest  2,183  in Innovator Premium Income on September 3, 2024 and sell it today you would earn a total of  211.00  from holding Innovator Premium Income or generate 9.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy59.6%
ValuesDaily Returns

Pfizer Inc  vs.  Innovator Premium Income

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Innovator Premium Income 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator Premium Income are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable fundamental indicators, Innovator Premium is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pfizer and Innovator Premium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Innovator Premium

The main advantage of trading using opposite Pfizer and Innovator Premium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Innovator Premium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Premium will offset losses from the drop in Innovator Premium's long position.
The idea behind Pfizer Inc and Innovator Premium Income pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals